Harvia Oyj
Harvia Plc’s financial information and Annual General Meeting in 2026
Harvia Plc’s financial information and Annual General Meeting in 2026
Harvia Plc, Stock Exchange Release, 7 August 2025 at 1:00 p.m. EEST
Harvia Plc’s financial information and Annual General Meeting in 2026
Harvia will publish its financial statements for 2025 and interim reports in 2026 as follows:
· 12 February 2026 Financial statements bulletin for 2025
· 7 May 2026 January−March 2026 interim report
· 6 August 2026 Half-year (January−June) 2026 financial report
· 29 October 2026 January−September 2026 interim report
Harvia’s electronic annual report, which contains the complete Financial Statements 2025, will be published during the week starting 9 March 2026 (week 11/2026).
Harvia’s Annual General meeting will be held on 15 April 2026 at 10:00 a.m. in Helsinki. The exact location will be announced later.
Further information:
Ari Vesterinen, CFO
tel: +358 40 5050 440
ari.vesterinen@harvia.com
Harvia is one of the leading companies operating in the sauna market globally, as measured by revenue. Harvia’s brands and product portfolio are well known in the market, and the company’s comprehensive product portfolio strives to meet the needs of the international sauna market of both private and professional customers.
Harvia’s revenue totaled EUR 175.2 million in 2024. Harvia Group employs approximately 700 professionals in Finland, United States, Germany, Romania, China and Hong Kong, Austria, Italy, Estonia, and Sweden. The company is headquartered in Muurame, Finland, adjacent to its largest sauna and sauna component manufacturing facility.
Read more: https://harviagroup.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Boehringer Ingelheim Limited8.8.2025 21:25:53 CEST | Press release
U.S. FDA grants accelerated approval to Boehringer’s HERNEXEOS® as first orally administered targeted therapy for previously treated patients with HER2-mutant advanced NSCLC
European Investment Bank8.8.2025 18:07:24 CEST | Press release
EIB submits SEC Form 18-K/A Amendment No. 4 - Unaudited Condensed Semi-Annual Financial Statements as at and for the six-month period ended June 30, 2025
European Investment Bank8.8.2025 18:04:10 CEST | Press release
EIB submits Form 18-K/A Amendment No.3 - December 2024 EIB Group Risk Management Disclosure Report
SBM Offshore Amsterdam B.V.8.8.2025 18:01:27 CEST | Press release
FPSO ONE GUYANA producing and on hire
Vaisala Group8.8.2025 17:30:00 CEST | Press release
Vaisala Corporation: Share Repurchase 8.8.2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom